Menu
Close
Home
About ImmuneOnco
About Us
Core Team
Development Strategy
ESG Report
Scientific Technology and R&D
Technology Platform
Product Pipeline
Latest Development
Company News
Investor Relations
Information Disclosure
Presentations
Corporate Governance
Investor Calendar
IR Contact
Join Us
Contact Us
Global
CN
TC
Home
CN
TC
About ImmuneOnco
About Us
Core Team
Development Strategy
ESG Report
Scientific Technology and R&D
Technology Platform
Product Pipeline
Scientific News
Company News
Investor Relations
Information Disclosure
Corporate Governance
Investor Calendar
Presentation Materials
Stock Information
Analyst Coverage
IR Contact
Email Subscription Center
Join Us
Contact Us
>
×
Investor Relations
Information Disclosure
Announcements and Circulars
Financial Reports
Listing Documents
Year
2025
2024
2023
Month
12
11
10
09
08
07
06
05
04
03
02
01
2023-10-04
Next Day Disclosure Return
2023-09-28
PARTIAL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD
2023-09-27
VOLUNTARY ANNOUNCEMENT - UPDATES ON THE CLINICAL TRIAL OF IMM47
2023-09-26
ANNOUNCEMENT INTERIM REPORT FOR THE SIX MONTHS ENDED JUNE 30, 2023
2023-09-13
DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCT
2023-09-11
VOLUNTARY ANNOUNCEMENT - UPDATES ON THE CLINICAL TRIALS OF IMM2510 AND IMM27M
2023-09-04
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2023-09-04
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE
2023-09-04
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE
2023-09-04
TERMS OF REFERENCE OF THE AUDIT COMMITTEE
2023-09-04
ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS
2023-08-24
GREEN APPLICATION FORM
2023-08-24
GLOBAL OFFERING
2023-08-24
GLOBAL OFFERING
总计 94
1
2
3
4
5